About Michael Berendt
Form D filings for Response Pharmaceuticals in 2024 list Michael Berendt as director.
Michael Berendt first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Berendt in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Berendt works with at each company, as listed on that company's latest Form D.
Response Pharmaceuticals, Inc. · Form D, Jun 28, 2024
DO
Donald Olds
Director
EK
Eric Keller
President and CEO, director